Merck (MRK): Officer exercised options on 58K shares
Richard R. Deluca, Officer at Merck, reported an option exercise of 58K shares.
- 58K
- Shares · @ $77.62
- Traded
- Nov 12, 2026
- Filed
- Nov 16, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 14, 2026Federal contract · $1.6M obligatedDepartment of Health and Human Services awarded Merck: $1.63M obligated to date
- Sep 21, 2026FDAFDA drug approval: Winrevair
- Sep 24, 2026FDAFDA drug approval: Welireg
- Sep 24, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Merck: $21K obligated to date
- Sep 24, 2026CongressDisclosed partial sale of MRK — reported range $1,001 - $15,000
- Oct 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“(d) Incorporated by reference is a press release issued by Merck & Co., Inc. (the “Company”) on October 13, 2026, attached as Exhibit 99.1, announcing the election of Paul J. Diaz to the Company’s Board of Directors (the “Board”), effective November 1, 2026.”
- Oct 14, 2026FDAFDA drug approval: Enflonsia
- Oct 16, 2026FDAFDA drug approval: Keytruda
- Oct 16, 2026FDAFDA drug approval: Keytruda Qlex
- Oct 29, 2026Company filing · Form 8-K · ResultsReported its results
- Nov 12, 2026InsiderOfficer sold ~$8.61M of MRK shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Merck
For Merck, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 3 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRK page.
Other recent filings by Richard R. Deluca, EVP&Pres, Merck Animal Heallth
- SEC Form 4 at Merck (MRK)Nov 16, 2026
- SEC Form 4 at Merck (MRK)Aug 12, 2026
- SEC Form 4 at Merck (MRK)Aug 12, 2026
- SEC Form 4 at Merck (MRK)Aug 12, 2026
- SEC Form 4 at Merck (MRK)Aug 12, 2026
The full history of Richard R. Deluca, EVP&Pres, Merck Animal Heallth is on the profile page.
How this filing works
Explore the data
Common questions
Which Merck (MRK) insider traded, and how much?
Richard R. Deluca, Officer at Merck, reported an option exercise of 58K shares. At $77.62.
When did it happen, and when was it made public?
Traded: Nov 12, 2026. Filed: Nov 16, 2026. That is 4 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Merck recently?
For Merck, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 3 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the MRK page.
Does this mean MRK stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Merck
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 144Nov 12, 2026
- SEC Form 144Nov 2, 2026
- House Clerk periodic transaction reportOct 7, 2026
- USAspending.gov award recordSep 24, 2026
Everything OQRO holds on this company is on its MRK page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
